A Randomised Trial Evaluating Continuous Subcutaneous Infusion of Formulations of NN1218 and NovoLog® in Subjects With Type 1 Diabetes
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Novo Nordisk A/S
Related studies linked through entity extraction aliases.
Comparison of the Efficacy and Safety of Two Different Dose Adjustment Regimens for Insulin Degludec/Insulin Aspart in Subjects With Type 2 Diabetes Mellitus Previously Treated With Insulin Glargine
- Status
- COMPLETED
- Phase
- PHASE3
Investigation of Pain During Subcutaneous Injections With Different Injection Speed and Volume Combinations
- Status
- COMPLETED
- Phase
- PHASE1
The Efficacy of Insulin Degludec/Liraglutide in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on GLP-1 Receptor Agonist and OAD Therapy
- Status
- COMPLETED
- Phase
- PHASE3
Hormone Deficiency After Brain Injury During Combat
- Status
- UNKNOWN
- Phase
- N/A
Effects of Liraglutide on Kidney Function in Type 2 Diabetic Patients
- Status
- COMPLETED
- Phase
- PHASE4
The Effect of Insulin Degludec in Combination With Liraglutide and Metformin in Subjects With Type 2 Diabetes Qualifying for Treatment Intensification
- Status
- COMPLETED
- Phase
- PHASE3
Safety and Efficacy of Biphasic Insulin Aspart 50 in Subjects With Type 2 Diabetes
- Status
- COMPLETED
- Phase
- PHASE3
Safety and Efficacy of Insulin Aspart in Type 2 Diabetes
- Status
- COMPLETED
- Phase
- PHASE4
A Randomised, Double-blind, Placebo-controlled, Parallel-group Trial to Assess Clinical Efficacy of NNC0114-0006 in Subjects With Active Rheumatoid Arthritis
- Status
- COMPLETED
- Phase
- PHASE2
A Trial of NNC0109-0012, an Anti-IL-20 Biologic, in Patients With Active Rheumatoid Arthritis Who Are Inadequate Responders to Methotrexate
- Status
- TERMINATED
- Phase
- PHASE2
A Trial of NNC0109-0012, an Anti-IL-20 Biologic, in Patients With Active Rheumatoid Arthritis Who Are Inadequate Responders to Anti-TNFa Biologics
- Status
- TERMINATED
- Phase
- PHASE2
A Multi-centre, Open Labelled, Multiple Dosing Trial Investigating Safety, Pharmacokinetics and Pharmacodynamics of NNC 0172-2021 Administered Subcutaneously to Healthy Male Subjects and Haemophilia Subjects
- Status
- TERMINATED
- Phase
- PHASE1
Study of Liraglutide in Individuals With Type 2 Diabetes Using Insulin
- Status
- TERMINATED
- Phase
- PHASE3
French Observational Survey to Assess Hypoglycaemia in Insulin-treated Diabetic Patients
- Status
- COMPLETED
- Phase
- N/A
Severe Decrease of Growth Velocity in Children With Anorexia Nervosa.Therapeutic Trial of Growth Hormone
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
A Trial Investigating the Absolute Bioavailability of Insulin Degludec in Healthy Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Efficacy and Safety of Liraglutide Versus Placebo as add-on to Existing Diabetes Medication in Subjects With Type 2 Diabetes and Moderate Renal Impairment
- Status
- COMPLETED
- Phase
- PHASE3
Safety and Tolerability of Liraglutide in Healthy Japanese Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Liraglutide in Healthy Japanese Volunteers
- Status
- COMPLETED
- Phase
- PHASE1